Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

Wild Card Prurisol comes through. When the company switched from testing Prurisol from moderate to severe psoriasis to mild to moderate it might been better to switch the scoring system as well. With the IGA scale in mild to moderate cases Prurisol would have had to nearly clear all of the psoriasis in a short-time period. Another Monday quarterback comment comes with using the 50 and 100 mg at all.

Looking forward to data on the time-scale on this trial to see what role duration plays with clearing psoriasis at the 200 dose level. Really just hoping this is enough to get a partner for Prurisol so we can get trucking with Kevetrin and Brilacidin.